hydromorphone hydrochloride
NDC 31722-119, hydromorphone hydrochloride, tablet, extended release, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-119
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212133
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/31722-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROMORPHONE HYDROCHLORIDE8 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-119-01 | 31722011901 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-119-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c33e6320-4206-4b69-8cac-ebfc2351b8f2NADAC price for package 31722011901
GET /v1/drugs/nadac/31722011901
Use it
Look up 31722-119 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.